Stay updated on ANZUP UNICAB Trial: Immunotherapy in Non-Clear Cell

Sign up to get notified when there's something new on the ANZUP UNICAB Trial: Immunotherapy in Non-Clear Cell page.
Latest website image capture
Clouds background image

Latest updates to the ANZUP UNICAB Trial: Immunotherapy in Non-Clear Cell page

  1. Check
    yesterday
    Change Detected
    Summary
    No additions or deletions were detected on the page; the content appears unchanged.
    Difference
    0.4%
    Check dated 2025-10-27T21:09:27.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    - Core page content updated to reflect current operating status and guidance; version updated from v3.1.0 to v3.2.0. - Adds a prominent notice about funding lapse impacts and where to check status.
    Difference
    3%
    Check dated 2025-10-06T08:39:25.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag.
    Difference
    0.1%
    Check dated 2025-09-29T05:22:34.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed. This is a minor metadata/UI update with no substantive changes to core content.
    Difference
    0.2%
    Check dated 2025-09-14T23:20:00.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T19:52:19.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as updates to the classification of renal cell carcinoma types and the introduction of cabozantinib. The revision number has also been updated to v3.0.0.
    Difference
    2%
    Check dated 2025-08-31T12:32:33.000Z thumbnail image

Stay in the know with updates to ANZUP UNICAB Trial: Immunotherapy in Non-Clear Cell

Enter your email address, and we'll notify you when there's something new on the ANZUP UNICAB Trial: Immunotherapy in Non-Clear Cell page.